1. Home
  2. PRTA vs ADV Comparison

PRTA vs ADV Comparison

Compare PRTA & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • ADV
  • Stock Information
  • Founded
  • PRTA 2012
  • ADV 1987
  • Country
  • PRTA Ireland
  • ADV United States
  • Employees
  • PRTA N/A
  • ADV N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • ADV Business Services
  • Sector
  • PRTA Health Care
  • ADV Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • ADV Nasdaq
  • Market Cap
  • PRTA 809.8M
  • ADV 875.7M
  • IPO Year
  • PRTA N/A
  • ADV N/A
  • Fundamental
  • Price
  • PRTA $15.27
  • ADV $2.15
  • Analyst Decision
  • PRTA Buy
  • ADV
  • Analyst Count
  • PRTA 9
  • ADV 0
  • Target Price
  • PRTA $54.57
  • ADV N/A
  • AVG Volume (30 Days)
  • PRTA 396.4K
  • ADV 364.7K
  • Earning Date
  • PRTA 05-07-2025
  • ADV 03-07-2025
  • Dividend Yield
  • PRTA N/A
  • ADV N/A
  • EPS Growth
  • PRTA N/A
  • ADV N/A
  • EPS
  • PRTA N/A
  • ADV N/A
  • Revenue
  • PRTA $135,157,000.00
  • ADV $3,566,324,000.00
  • Revenue This Year
  • PRTA N/A
  • ADV N/A
  • Revenue Next Year
  • PRTA $106.71
  • ADV $2.02
  • P/E Ratio
  • PRTA N/A
  • ADV N/A
  • Revenue Growth
  • PRTA 47.92
  • ADV N/A
  • 52 Week Low
  • PRTA $11.70
  • ADV $2.04
  • 52 Week High
  • PRTA $30.86
  • ADV $4.95
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 54.26
  • ADV 31.09
  • Support Level
  • PRTA $13.89
  • ADV $2.26
  • Resistance Level
  • PRTA $16.16
  • ADV $2.69
  • Average True Range (ATR)
  • PRTA 1.14
  • ADV 0.15
  • MACD
  • PRTA 0.04
  • ADV -0.03
  • Stochastic Oscillator
  • PRTA 53.11
  • ADV 16.31

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About ADV Advantage Solutions Inc.

Advantage Solutions Inc is the provider of outsourced sales and marketing solutions to consumer goods companies and retailers. It has a technology-enabled platform of sales and marketing services like headquarter sales, retail merchandising, in-store sampling, digital commerce, and shopper marketing. For brands and retailers of all sizes, the firm helps to get the right products on the shelf and into the hands of consumers. The company helps its clients to sell more while spending less. Advantage has offices throughout North America and strategic investments in select markets throughout Africa, Asia, Australia, and Europe through which it services the global needs of multinational, regional, and local manufacturers. Its services are provided across two segments sales and marketing.

Share on Social Networks: